DOJ Backs Biosimilar Makers In Info-Sharing Fight
The U.S. Department of Justice on Monday sided with biosimilar makers in the aftermath of a major U.S. Supreme Court ruling involving Amgen and Sandoz, telling the Federal Circuit that state...To view the full article, register now.
Already a subscriber? Click here to view full article